))
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
…
continue reading
The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Sages of Psychopharmacology Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.
…
continue reading
1
Distinguishing Postpartum OCD from Psychosis
13:39
13:39
Spill senere
Spill senere
Lister
Lik
Likt
13:39
In this episode, we explore the critical distinction between postpartum OCD and postpartum psychosis. Dr. Lauren Osborne reveals why accurate diagnosis matters for treatment and safety. Did you know intrusive thoughts about infant harm don't actually indicate elevated risk in OCD, but do in psychosis? Faculty: Lauren Osborne, M.D. Host: Richard See…
…
continue reading
1
Do SSRI Side Effects Improve Over Time?
11:13
11:13
Spill senere
Spill senere
Lister
Lik
Likt
11:13
In this episode, we examine groundbreaking research that challenges the widespread clinical belief that SSRI side effects improve with time. Using data from the landmark STAR*D trial, we explore which patients actually experience side effect resolution and which face worsening symptoms. Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D. Learn…
…
continue reading
1
Beyond Lithium Monotherapy: Evidence-Based Augmentation in Acute Mania
7:43
7:43
Spill senere
Spill senere
Lister
Lik
Likt
7:43
In this episode, we explore evidence-based strategies for augmenting lithium when monotherapy fails in acute mania. Why is quetiapine the preferred add-on to valproate, despite decades of clinical tradition favoring anticonvulsants? Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: An Update …
…
continue reading
1
Choosing First-Line Antipsychotics: Considering Violence
13:42
13:42
Spill senere
Spill senere
Lister
Lik
Likt
13:42
In this episode, we explore a groundbreaking Mayo Clinic algorithm that revolutionizes antipsychotic selection for first-episode psychosis. Should the presence of violence completely change your medication choice strategy? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CME: Quick Take Vo…
…
continue reading
1
Beyond Antipsychotics: Using Lithium in Mania
15:05
15:05
Spill senere
Spill senere
Lister
Lik
Likt
15:05
In this episode, we challenge conventional prescribing by exploring why lithium should be the first-line treatment for acute classic mania, despite widespread use of antipsychotics. Dr. David Osser presents evidence-based arguments for lithium's unique neuroprotective benefits and long-term efficacy. Faculty: David Osser, M.D. Host: Richard Seeber,…
…
continue reading
1
Trazodone vs. Doxepin vs. Melatonin: Comparing Alternatives for Sleep
11:12
11:12
Spill senere
Spill senere
Lister
Lik
Likt
11:12
In this episode, we explore a head-to-head comparison of trazodone, doxepin, and melatonin for treating insomnia when benzodiazepines are off the table. Which non-benzodiazepine sleep aid offers the best balance of effectiveness and tolerability in real-world psychiatric patients? Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D. Learn more …
…
continue reading
1
Beyond Monotherapy: Mixed Episode Management
11:40
11:40
Spill senere
Spill senere
Lister
Lik
Likt
11:40
In this episode, we explore the critical decision of when to add lithium or valproate to second-generation antipsychotics in mixed manic episodes. Should you rush to combination therapy under managed care pressure, or does patience with strategic benzodiazepine bridging lead to better outcomes? Faculty: David Osser, M.D. Host: Richard Seeber, M.D. …
…
continue reading
1
Old Drug, New Perspectives: Disulfiram's and Addiction Medicine
8:58
8:58
Spill senere
Spill senere
Lister
Lik
Likt
8:58
In this episode, we explore a provocative argument for reconsidering disulfiram as a first-line treatment for alcohol use disorder. Could this decades-old medication, often dismissed as outdated and dangerous, actually be more effective than newer alternatives when used in appropriately selected patients? Faculty: David Gorelick, M.D. Host: Richard…
…
continue reading
1
Quetiapine vs. Lithium in Mixed Bipolar States
13:52
13:52
Spill senere
Spill senere
Lister
Lik
Likt
13:52
In this episode, we explore the complex pharmacological management of mixed mania, a challenging bipolar presentation affecting up to 40% of manic episodes. Why do traditional mood stabilizers like lithium fall short, and which second-generation antipsychotics emerge as first-line treatments for this dual-symptom condition? Faculty: David Osser, M.…
…
continue reading
1
Psychedelic-Assisted Therapy: Redefining Treatment
17:19
17:19
Spill senere
Spill senere
Lister
Lik
Likt
17:19
In this episode, we explore psychedelic-assisted therapy in clinical practice, examining how these treatments differ fundamentally from traditional pharmacotherapy. Can psychiatrists reconcile mystical experiences with evidence-based medicine while navigating the complex therapeutic paradigm of preparation, 8-hour sessions, and integration work? Fa…
…
continue reading
1
Lurasidone's Therapeutic Window: Is Less More?
13:50
13:50
Spill senere
Spill senere
Lister
Lik
Likt
13:50
In this episode, we explore groundbreaking research revealing that lower doses of lurasidone (40-60mg) may be more effective for bipolar depression than higher doses. Could we be over-medicating our patients when the sweet spot for both efficacy and tolerability lies in this unexpected lower range? Faculty: Kristin Raj, M.D. Host: Richard Seeber, M…
…
continue reading
1
Beyond Black Box Warnings: Choosing Antipsychotics in Dementia
11:30
11:30
Spill senere
Spill senere
Lister
Lik
Likt
11:30
In this episode, we explore a compelling comparison between olanzapine and risperidone for managing behavioral symptoms in dementia patients. Are the delusions we see in Alzheimer's disease actually true delusions, or something entirely different that requires a new treatment approach? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn mor…
…
continue reading
1
SSRIs and Psychedelics: Drug Interactions
11:14
11:14
Spill senere
Spill senere
Lister
Lik
Likt
11:14
In this episode, we explore the complex drug-drug interactions between psychedelics and psychiatric medications. Do SSRIs really blunt psychedelic effects, or is this just clinical folklore? We'll examine surprising new research and discuss potentially dangerous combinations every psychiatrist should know. Faculty: Franklin King, M.D. Host: Richard…
…
continue reading
